Therefore, to explore potential isoform-specific functions of Dyn1 and Dyn2, as well as the role of GSK3β in regulating Dyn1 activity, we generated genome-edited H1299 non-small cell lung cancer cells, which we previously showed partially utilize Dyn1 for CME [23]. This evidence concerns the gene GSK3B and non-small cell lung carcinoma.